APA (7th ed.) Citation

Hausen, G. z., Springfeld, C., Härtel, N., & Hofheinz, R. (2016). Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values: Data from the German QoliXane pancreatic cancer registry. Annals of oncology, 27, . https://doi.org/10.1093/annonc/mdw371.76

Chicago Style (17th ed.) Citation

Hausen, Gerrit zur, Christoph Springfeld, Nicolai Härtel, and Ralf-Dieter Hofheinz. "Nab-paclitaxel/gemcitabine First Line Therapy in Patients with Metastatic Pancreatic Carcinoma and High-bilirubin Values: Data from the German QoliXane Pancreatic Cancer Registry." Annals of Oncology 27 (2016). https://doi.org/10.1093/annonc/mdw371.76.

MLA (9th ed.) Citation

Hausen, Gerrit zur, et al. "Nab-paclitaxel/gemcitabine First Line Therapy in Patients with Metastatic Pancreatic Carcinoma and High-bilirubin Values: Data from the German QoliXane Pancreatic Cancer Registry." Annals of Oncology, vol. 27, 2016, https://doi.org/10.1093/annonc/mdw371.76.